Voice of the Diabetic

Back|

Next|

Table of Contents|

Home

NEW THERAPY MAY INHABIT RETINOPATHY

The days of "laser surgery"

may be numbered. GenVec, Inc., a Maryland-based pharmaceutical research firm,

has obtained exclusive license to PEDF, pigment epithelium- derived factor,

a substance developed by researchers at Northwestern University. PEDF appears

to inhibit the abnormal capillary growth we know as diabetic retinopathy, which

Voice of the Diabetic

Back|

Next|

Table of Contents|

Home

GLUCOWATCH APPROVED

On March 22, 2001, The

U.S. Food and Drug Administration (FDA) announced that it had completed the

approval process for the Glucowatch Biographer continuous glucose monitor. It's

passed; it's here; it will now come to market. Worn like a big wristwatch, the

Glucowatch is the first working alternative to "lancet and test-strip" blood

glucose monitors to reach "approval" status.

Voice of the Diabetic

Back||

Table of Contents|

Home

FOOD FOR THOUGHT

Artwork: Dancing fruit

and vegetables.

We invite blurbs and tidbit

articles for inclusion in this column. Materials received may be edited and

used as space permits. Products and services included in this column are for

information only and do not imply endorsement by the Diabetes Action Network

of the NFB.

INHALED INSULIN PROGRESS

Generex Biotechnology has

Voice of the Diabetic: Table of Contents

VOICE OF THE DIABETIC

The Diabetes Action Network of the National

Federation of the Blind

A Support and Information Network

Volume 16, Number 2, Spring Edition 2001

VOICE OF THE DIABETIC, published quarterly, is

the national news magazine of the Diabetes Action Network of the National Federation

of the Blind. It is read by those interested in all aspects of blindness and

diabetes. We show diabetics that they have options regardless of the ramifications

Voice of the Diabetic: Table of Contents

VOICE OF THE DIABETIC

The Diabetes Action Network of the National
Federation of the Blind
A Support and Information Network
Volume 16, Number 2, Spring Edition 2001

Voice of the Diabetic

Back|

Next|

Table of Contents|

Home

MY JOURNEY WITH DIABETES

by Lois Willams

From the Editor: Lois Williams is a Board Member of

the Diabetes Action Network of the National Federation of the Blind. She also

leads the way on Diabetes Action Network activities for the NFB of Alabama.

Lois is inspiring and optimistic, as she strives to educate

people about diabetes and its ramifications. She knows the importance of having

Voice of the Diabetic

Back|

Next|

Table of Contents|

Home

YOUR DIABETES CARE SHOULD FIT YOU

by Ann S. Williams, MSN, RN, CDE

This is a new column, which will appear regularly in the VOICE

OF THE DIABETIC. I have chosen "Your Diabetes Care Should Fit You"

as its title because this is my general philosophy as a Diabetes Educator. I

try to help each individual person find how to make their own diabetes care

fit well with their own needs and the life they lead.

Voice of the Diabetic

Back|

Next|

Table of Contents|

Home

2002 NATIONAL CONVENTION

It will soon be time for the 2002 convention of the National

Federation of the Blind, to be held at the Galt House Hotel, 140 N. Fourth Street,

Louisville, Kentucky 40202. The Galt House, site of our 1985 NFB convention,

is a beautiful hotel, in a convenient, central location.

To receive our special NFB National Convention rates, phone the Galt House at:

Voice of the Diabetic

Back|

Next|

Table of Contents|

Home

FLYING WITH DIABETES SUPPLIES?

The Federal Aviation Administration (FAA) has implemented stepped-up

security measures at the nation's airports in response to the September 11 attacks.

Some measures may affect airline passengers with diabetes. Here is an update:

1. Passengers may board with syringes or insulin delivery systems

once it is determined that the he or she has a documented medical need. Your

Voice of the Diabetic

Back|

Next|

Table of Contents|

Home

NEW FDA BLOOD-TEST GUIDELINES

A number of new glucose monitors have offered the opportunity

to test blood drawn from sites other than the fingers. These meters work, but

the Food and Drug Administration has been concerned about the "comparability"

of blood glucose tests drawn from the fingers and from alternate sites such

as the forearm, the upper leg, or elsewhere on the body. Research has been completed,